Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Stay updated with breaking news from Jan De Witte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Full-Year Revenue Sees Slight Decline as Company Prepares for 2024 with Strategic Acquisitions and Product Relaunches
Integra LifeSciences Holdings Corporation (IART) reported fourth quarter GAAP net income of $19.8 million, or $0.25 per share, compared to $52.9 million, or $0.63 per share, in the prior year.
05.01.2024 - PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the ...
Integra LifeSciences announced that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech.